EMA

European Medicines Agency

European UnionEuropeNational / regional regulator

EU agency coordinating scientific evaluation and GMP/GVP guidance across member-state authorities.

Browse the standards library →Official site ↗

WHAT EMA COVERS

The European Medicines Agency is the EU’s scientific agency for human and veterinary medicines. It coordinates evaluation and safety monitoring across the Union, most visibly through the centralised authorisation procedure that produces a single marketing authorisation valid in all member states. Its scientific committees — CHMP for human medicines, PRAC for pharmacovigilance risk, CVMP for veterinary — do the assessment work.

WHERE IT SITS INTERNATIONALLY

EMA is an ICH member, and EU authorities are founding participants in PIC/S. The EU-US Mutual Recognition Agreement allows reliance on each other’s GMP inspections for many human medicines, reducing duplicate inspection of the same site.

HOW ITS REQUIREMENTS BITE

EMA is a coordinating agency, not an inspectorate: GMP and GCP inspections are performed by the national competent authorities of the member states, and EMA coordinates them, maintains the shared EudraGMDP database of certificates and non-compliance reports, and manages EudraVigilance for safety data. Legal decisions on centralised authorisations are taken by the European Commission on EMA’s scientific opinion.

WHAT EMA PUBLISHES

  1. 01Scientific guidelines and reflection papers for human and veterinary medicines
  2. 02Good Pharmacovigilance Practices (GVP) Modules I–XVI
  3. 03European Public Assessment Reports (EPARs) for authorised products
  4. 04EudraGMDP entries — GMP/GDP certificates and non-compliance reports
  5. 05Q&A documents that often carry the practical detail behind a guideline

WHAT PRACTITIONERS GET WRONG

  • EMA does not inspect — member-state authorities do; a "EMA inspection" is really a national inspection coordinated through EMA.
  • EMA gives a scientific opinion; the legally binding decision on a centralised authorisation is the European Commission’s.
  • GMP text itself is published by the Commission in EudraLex Volume 4, not by EMA.
  • EudraGMDP is the public record of who holds a valid GMP certificate — and who has a non-compliance report.

EMA STANDARDS SPEQ DECODES · 6

EU GMP Annex 1 (2022)HIGH INSPECTION RISK
Manufacture of Sterile Medicinal Products
EU GMP Annex 11HIGH INSPECTION RISK
Computerised Systems
EU GMP Annex 15
Qualification and Validation
EU GMP Annex 2
Manufacture of Biological Active Substances and Medicinal Products for Human Use
Regulation (EU) 536/2014HIGH INSPECTION RISK
Clinical Trials Regulation (CTR)
EU GVP ModulesHIGH INSPECTION RISK
EU Good Pharmacovigilance Practices (GVP)

DISCIPLINES IN EMA’S REMIT

GMPGood Manufacturing PracticeGCPGood Clinical PracticeGVPGood Pharmacovigilance PracticeCSVComputerised System Validation
Weekly Briefing

Track EMA — and every regulator that matters

New rules, guidance, enforcement, and inspection signals from European Medicines Agency and its peers worldwide, distilled into the free Weekly GxP Briefing.

Read a past issue →